These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 38360860)

  • 61. [Soft tissue angiosarcoma in a child. Immunohistochemical and ultrastructural features].
    Sastre-Garau X; Thiery JP; Ovtracht L; Gallet C; Quintana E; Laurent M
    Ann Pathol; 1992; 12(1):34-40. PubMed ID: 1580939
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The Landscape of Immunotherapy for Retroperitoneal Sarcoma.
    Gingrich AA; Nassif EF; Roland CL; Keung EZ
    Curr Oncol; 2023 Feb; 30(2):2144-2158. PubMed ID: 36826126
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Alterations of routine blood tests in adult patients with soft tissue sarcomas: relationships to cytokine serum levels and prognostic significance.
    Ruka W; Rutkowski P; Kaminska J; Rysinska A; Steffen J
    Ann Oncol; 2001 Oct; 12(10):1423-32. PubMed ID: 11762815
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Single nucleotide polymorphism in fibroblast growth factor receptor 4 at codon 388 is associated with prognosis in high-grade soft tissue sarcoma.
    Morimoto Y; Ozaki T; Ouchida M; Umehara N; Ohata N; Yoshida A; Shimizu K; Inoue H
    Cancer; 2003 Nov; 98(10):2245-50. PubMed ID: 14601095
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Novel fusion sarcomas including targetable NTRK and ALK.
    Chen T; Wang Y; Goetz L; Corey Z; Dougher MC; Smith JD; Fox EJ; Freiberg AS; Flemming D; Fanburg-Smith JC
    Ann Diagn Pathol; 2021 Oct; 54():151800. PubMed ID: 34464935
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Aberrant immunohistochemical expression in nonrhabdomyosarcoma soft tissue sarcomas of infancy: retrospective review of clinical material.
    Sebire NJ; Ramsay AD; Levitt G; Malone M; Risdon RA
    Pediatr Dev Pathol; 2002; 5(6):579-86. PubMed ID: 12370769
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Molecular phenotyping using networks, diffusion, and topology: soft tissue sarcoma.
    Mathews JC; Pouryahya M; Moosmüller C; Kevrekidis YG; Deasy JO; Tannenbaum A
    Sci Rep; 2019 Sep; 9(1):13982. PubMed ID: 31562358
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pseudoendocrine Sarcoma: Clinicopathologic Analysis of 23 Cases of a Distinctive Soft Tissue Neoplasm With Metastatic Potential, Recurrent CTNNB1 Mutations, and a Predilection for Truncal Locations.
    Papke DJ; Dickson BC; Sholl L; Fletcher CDM
    Am J Surg Pathol; 2022 Jan; 46(1):33-43. PubMed ID: 34081037
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Angiosarcoma of soft tissue: a study of 80 cases.
    Meis-Kindblom JM; Kindblom LG
    Am J Surg Pathol; 1998 Jun; 22(6):683-97. PubMed ID: 9630175
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Identification of a novel MTAP-RAF1 fusion in a soft tissue sarcoma.
    Hicks JK; Henderson-Jackson E; Duggan J; Joyce DM; Brohl AS
    Diagn Pathol; 2018 Oct; 13(1):77. PubMed ID: 30314519
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A Combined Risk Score Model to Assess Prognostic Value in Patients with Soft Tissue Sarcomas.
    Li Z; Duan Z; Jia K; Yao Y; Liu K; Qiao Y; Gao Q; Yang Y; Li G; Shang A
    Cells; 2022 Dec; 11(24):. PubMed ID: 36552841
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Histology-Driven Therapy: The Importance of Diagnostic Accuracy in Guiding Systemic Therapy of Soft Tissue Tumors.
    Noujaim J; Thway K; Sheri A; Keller C; Jones RL
    Int J Surg Pathol; 2016 Feb; 24(1):5-15. PubMed ID: 26399578
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Soft tissue sarcomas: From a morphological to a molecular biological approach.
    Oda Y; Yamamoto H; Kohashi K; Yamada Y; Iura K; Ishii T; Maekawa A; Bekki H
    Pathol Int; 2017 Sep; 67(9):435-446. PubMed ID: 28759137
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Epithelial-type and neural-type cadherin expression in malignant noncarcinomatous neoplasms with epithelioid features that involve the soft tissues.
    Laskin WB; Miettinen M
    Arch Pathol Lab Med; 2002 Apr; 126(4):425-31. PubMed ID: 11900566
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The clinical prognostic significance of ezrin in patients with bone and soft tissue sarcomas: a meta-analysis.
    Wang F; Yu T; Ma C; Zhang H; Zhang Z
    FEBS Open Bio; 2019 Oct; 9(10):1744-1755. PubMed ID: 31376222
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Current and advancing systemic treatment options for soft tissue sarcomas.
    Harris SJ; Benson C; Jones RL
    Expert Opin Pharmacother; 2015; 16(13):2023-37. PubMed ID: 26255951
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Analysis of gene expression profiles of soft tissue sarcoma using a combination of knowledge-based filtering with integration of multiple statistics.
    Takahashi A; Nakayama R; Ishibashi N; Doi A; Ichinohe R; Ikuyo Y; Takahashi T; Marui S; Yasuhara K; Nakamura T; Sugita S; Sakamoto H; Yoshida T; Hasegawa T; Takahashi H
    PLoS One; 2014; 9(9):e106801. PubMed ID: 25188299
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comprehensive profiling of immune-related genes in soft tissue sarcoma patients.
    Hu C; Chen B; Huang Z; Liu C; Ye L; Wang C; Tong Y; Yang J; Zhao C
    J Transl Med; 2020 Sep; 18(1):337. PubMed ID: 32873319
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Retrospective Analysis of the Clinical Presentation, Treatment and Outcome of Angiosarcoma in a Sarcoma Referral Center.
    Schöffski P; Timmermans I; Wildiers H; Dumez H; Hompes D; Christiaens M; Sciot R; Laenen A; Lee CJ; Meyskens T
    Oncol Res Treat; 2021; 44(6):322-332. PubMed ID: 33946082
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Risk assignment in pediatric soft-tissue sarcomas: an evolving molecular classification.
    Qualman SJ; Morotti RA
    Curr Oncol Rep; 2002 Mar; 4(2):123-30. PubMed ID: 11822984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.